Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Perol

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Sante Publique (Vandoeuvre-Les-Nancy, France)|May 6, 2010
[Collecting health expectations and indicators for teaching staff via the Internet: an original approach of the Observatory for Health Personnel at the University of Lyon]Adeline Zamora, Jean-Charles Cêtre, David Perol, et al.
Future Oncology (London, England)|December 16, 2021
CaboPoint: a phase II study of cabozantinib as second-line treatment in patients with metastatic renal cell carcinomaLaurence Albiges, Manuela Schmidinger, Naila Taguieva-Pioger, et al.
Cancer Letters|June 1, 2005
Protein chip array profiling analysis of sera from neuroblastoma patientsValérie Combaret, Christophe Bergeron, Stéphanie Bréjon, et al.
Journal of Visualized Experiments : Jove|January 29, 2019
Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver MetastasesAurélien Dupre, David Melodelima, David Perol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 19, 2005
Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinomaLine Claude, David Perol, Isabelle Ray-Coquard, et al.
BMJ Supportive & Palliative Care|July 3, 2025
Paediatric palliative care medical hotline: retrospective database studyTchadine Djaogol, Julien Gautier, Helene Martinez, et al.
Journal of Neuro-Oncology|June 15, 2007
Role of exclusive chemotherapy as first line treatment in oligodendrogliomaMarie Pierre Sunyach, Anne Jouvet, David Perol, et al.
The Journal of Vascular Access|September 1, 2025
Clinical benefit of adding cyanoacrylate glue during PICC line insertion compared to standard procedure in outpatient cancer patients: Results from the randomized prospective trial PICCandGLUEBenjamin Figari, Norvène Driffort, Aymeric De Montfort, et al.
Journal of Surgical Oncology|February 24, 2018
HEPATOFLUO: A prospective monocentric study assessing the benefits of indocyanine green (ICG) fluorescence for hepatic surgeryPatrice Peyrat, Ellen Blanc, Stéphanie Guillermet, et al.
Cancers|November 13, 2021
COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control StudyJulien Péron, Tristan Dagonneau, Anne Conrad, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Sante Publique (Vandoeuvre-Les-Nancy, France)|May 6, 2010
[Collecting health expectations and indicators for teaching staff via the Internet: an original approach of the Observatory for Health Personnel at the University of Lyon]Adeline Zamora, Jean-Charles Cêtre, David Perol, et al.
Future Oncology (London, England)|December 16, 2021
CaboPoint: a phase II study of cabozantinib as second-line treatment in patients with metastatic renal cell carcinomaLaurence Albiges, Manuela Schmidinger, Naila Taguieva-Pioger, et al.
Cancer Letters|June 1, 2005
Protein chip array profiling analysis of sera from neuroblastoma patientsValérie Combaret, Christophe Bergeron, Stéphanie Bréjon, et al.
Journal of Visualized Experiments : Jove|January 29, 2019
Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver MetastasesAurélien Dupre, David Melodelima, David Perol, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 19, 2005
Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinomaLine Claude, David Perol, Isabelle Ray-Coquard, et al.
BMJ Supportive & Palliative Care|July 3, 2025
Paediatric palliative care medical hotline: retrospective database studyTchadine Djaogol, Julien Gautier, Helene Martinez, et al.
Journal of Neuro-Oncology|June 15, 2007
Role of exclusive chemotherapy as first line treatment in oligodendrogliomaMarie Pierre Sunyach, Anne Jouvet, David Perol, et al.
The Journal of Vascular Access|September 1, 2025
Clinical benefit of adding cyanoacrylate glue during PICC line insertion compared to standard procedure in outpatient cancer patients: Results from the randomized prospective trial PICCandGLUEBenjamin Figari, Norvène Driffort, Aymeric De Montfort, et al.
Journal of Surgical Oncology|February 24, 2018
HEPATOFLUO: A prospective monocentric study assessing the benefits of indocyanine green (ICG) fluorescence for hepatic surgeryPatrice Peyrat, Ellen Blanc, Stéphanie Guillermet, et al.
Cancers|November 13, 2021
COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control StudyJulien Péron, Tristan Dagonneau, Anne Conrad, et al.
Pageof 6